Combined treatment of drug-resistant tuberculosis with bedaquiline and delamanid: a systematic review-Reference-Cited by-同舟云学术

Combined treatment of drug-resistant tuberculosis with bedaquiline and delamanid: a systematic review

Published:2018-06-14 Issue:1 Volume:52 Page:1800934
ISSN:0903-1936
Container-title:European Respiratory Journal
language:en
Short-container-title:Eur Respir J

Author:

Pontali Emanuele,Sotgiu Giovanni^ORCID,Tiberi Simon,Tadolini Marina,Visca Dina,D'Ambrosio Lia^ORCID,Centis Rosella^ORCID,Spanevello Antonio,Migliori Giovanni Battista^ORCID

Publisher

European Respiratory Society (ERS)

Subject

Pulmonary and Respiratory Medicine

Reference15 articles.

1. World Health Organization. Global Tuberculosis Report 2017. Geneva, World Health Organization, 2017.

2. World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update

3. Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study

4. Final treatment outcomes of multidrug- and extensively drug-resistant tuberculosis patients in Latvia receiving delamanid-containing regimens

5. Bedaquiline and multidrug-resistant tuberculosis: a systematic and critical analysis of the evidence

Cited by 70 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of effectiveness and safety of delamanid-containing regimens using individual patient datasets;The International Journal of Tuberculosis and Lung Disease;2024-09-01

2. Effectiveness of bedaquiline containing all oral longer regimens in treating multidrug/rifampicin resistant tuberculosis in Pakistan;Journal of Infection and Public Health;2024-09

3. Intranasal Administration of Bedaquiline-Loaded Fucosylated Liposomes Provides Anti-Tubercular Activity while Reducing the Potential for Systemic Side Effects;ACS Infectious Diseases;2024-08-13

4. Real-life use of delamanid: results from the European post-authorisation safety study;IJTLD OPEN;2024-06-01

5. Development of a self-microemulsifying drug delivery system to deliver delamanid via a pressurized metered dose inhaler for treatment of multi-drug resistant pulmonary tuberculosis;International Journal of Pharmaceutics;2024-04